New patterns of genetic instability in chronic myeloid leukemia: interesting, but not ready for clinical use

Affiliations

¹ Charles A. Schiffer, MD Professor Emeritus of Oncology Department of Oncology Karmanos Cancer Institute Wayne State University School of Medicine Detroit, MI 48302. schiffer@karmanos.org.

Editorial

Charles A Schiffer. Haematologica. 2023.

. 2023 Sep 1;108(9):2273-2274.

doi: 10.3324/haematol.2023.283059.

¹ Charles A. Schiffer, MD Professor Emeritus of Oncology Department of Oncology Karmanos Cancer Institute Wayne State University School of Medicine Detroit, MI 48302. schiffer@karmanos.org.

No abstract available

Comment on

Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention.
Shanmuganathan N, Wadham C, Shahrin N, Feng J, Thomson D, Wang P, Saunders V, Kok CH, King RM, Kenyon RR, Lin M, Pagani IS, Ross DM, Yong ASM, Grigg AP, Mills AK, Schwarer AP, Braley J, Altamura H, Yeung DT, Scott HS, Schreiber AW, Hughes TP, Branford S. Shanmuganathan N, et al. Haematologica. 2023 Sep 1;108(9):2380-2395. doi: 10.3324/haematol.2022.282184. Haematologica. 2023. PMID: 36951160 Free PMC article.

1. Schiffer CA. Commentary on the prescient observations made by Emil J Freireich in Effectiveness of platelet transfusion in leukemia and aplastic anemia (Transfusion 1966;6:50-54). Transfusion. 2022;62(2):267-272. - PubMed
1. Angelini S, Soverini S, Ravegnini G, et al. . Association between imatinib transporters and metabolizing enzymes genotype and response in newly diagnosed chronic myeloid leukemia patients receiving imatinib therapy. Haematologica. 2013;98(2):193-200. - PMC - PubMed
1. Radich JP, Wall M, Branford S, et al. . Molecular response in newly diagnosed chronic-phase chronic myeloid leukemia: prediction modeling and pathway analysis. Haematologica. 2023;108(6):1567-1578. - PMC - PubMed
1. Radich JP, Dai H, Mao M, et al. . Gene expression changes associated with progression and response in chronic myeloid leukemia. Proc Natl Acad Sci U S A. 2006;103(8):2794-2799. - PMC - PubMed
1. Shanmuganathan N, Wadham C, Shahrin N, et al. . Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment intervention. Haematologica. 2023;108(9)2380-2395. - PMC - PubMed